Sonoma Pharmaceuticals Inc Long-term Investment Intensity

Latest as of March 2015: 30.2%

Sonoma Pharmaceuticals Inc long-term investment intensity. Sonoma Pharmaceuticals Inc (SNOA) has a Long-term Investment Intensity of 30.2% as of March 2015. Long-term investments of $4.54 Million represent 30.2% of total assets of $15.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read debt load of Sonoma Pharmaceuticals Inc for a breakdown of total debt and financial obligations.

LT Investment Intensity

30.2%
LT Investments / Total Assets

Long-term Investments

$4.54 Million
USD

Total Assets

$15.05 Million
USD

Country

USA
NASDAQ

Long-term Investment Intensity of Sonoma Pharmaceuticals Inc (2014–2015)

Long-term investment intensity of Sonoma Pharmaceuticals Inc from 2014 to 2015. This chart shows how Sonoma Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2014 to 2015. As of March 2015, the intensity stands at 30.2%, reflecting long-term investments of $4.54 Million against total assets of $15.05 Million USD.

Sonoma Pharmaceuticals Inc Long-term Investment Intensity by Year (2014–2015)

Sonoma Pharmaceuticals Inc long-term investment intensity by year from 2014 to 2015. The table below presents the year-by-year Long-term Investment Intensity for Sonoma Pharmaceuticals Inc from 2014 to 2015, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SNOA total asset value.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2015 30.2% $4.54 Million $15.05 Million ▼ -18.7 pp
2014 48.8% $10.15 Million $20.79 Million —
pp = percentage points